• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种长停留时间烯酰还原酶抑制剂通过同工酶依赖性互变异构适应和不同的底物结合环闭合来探索扩展结合区域。

A Long Residence Time Enoyl-Reductase Inhibitor Explores an Extended Binding Region with Isoenzyme-Dependent Tautomer Adaptation and Differential Substrate-Binding Loop Closure.

作者信息

Eltschkner Sandra, Kehrein Josef, Le Thien Anh, Davoodi Shabnam, Merget Benjamin, Basak Sneha, Weinrich Jonas D, Schiebel Johannes, Tonge Peter J, Engels Bernd, Sotriffer Christoph, Kisker Caroline

机构信息

Rudolf Virchow Center for Integrative and Translational Bioimaging, Institute for Structural Biology, University of Würzburg, 97080 Würzburg, Germany.

Molecular Ecology and Evolution Lab, Department of Biology, Lund University, 223 62 Lund, Sweden.

出版信息

ACS Infect Dis. 2021 Apr 9;7(4):746-758. doi: 10.1021/acsinfecdis.0c00437. Epub 2021 Mar 12.

DOI:10.1021/acsinfecdis.0c00437
PMID:33710875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8791450/
Abstract

The enoyl-acyl carrier protein (ACP) reductase (ENR) is a key enzyme within the bacterial fatty-acid synthesis pathway. It has been demonstrated that small-molecule inhibitors carrying the diphenylether (DPE) scaffold bear a great potential for the development of highly specific and effective drugs against this enzyme class. Interestingly, different substitution patterns of the DPE scaffold have been shown to lead to varying effects on the kinetic and thermodynamic behavior toward ENRs from different organisms. Here, we investigated the effect of a 4'-pyridone substituent in the context of the slow tight-binding inhibitor SKTS1 on the inhibition of the enoyl-ACP-reductase saFabI and the closely related isoenzyme from , InhA, and explored a new interaction site of DPE inhibitors within the substrate-binding pocket. Using high-resolution crystal structures of both complexes in combination with molecular dynamics (MD) simulations, kinetic measurements, and quantum mechanical (QM) calculations, we provide evidence that the 4'-pyridone substituent adopts different tautomeric forms when bound to the two ENRs. We furthermore elucidate the structural determinants leading to significant differences in the residence time of SKTS1 on both enzymes.

摘要

烯酰-酰基载体蛋白(ACP)还原酶(ENR)是细菌脂肪酸合成途径中的一种关键酶。已证明,带有二苯醚(DPE)支架的小分子抑制剂在开发针对这类酶的高度特异性和有效药物方面具有巨大潜力。有趣的是,DPE支架的不同取代模式已显示出对来自不同生物体的ENR的动力学和热力学行为产生不同影响。在此,我们研究了在慢紧密结合抑制剂SKTS1背景下4'-吡啶酮取代基对烯酰-ACP还原酶saFabI以及来自结核分枝杆菌的密切相关同工酶InhA的抑制作用,并探索了DPE抑制剂在底物结合口袋内的一个新的相互作用位点。结合高分辨率晶体结构、分子动力学(MD)模拟、动力学测量和量子力学(QM)计算,我们提供证据表明,4'-吡啶酮取代基在与两种ENR结合时采用不同互变异构形式。我们还阐明了导致SKTS1在两种酶上停留时间存在显著差异的结构决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/5a4ecaee9f3b/nihms-1768675-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/ffccaef3a2d5/nihms-1768675-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/b188584d3609/nihms-1768675-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/1be7603ec2d6/nihms-1768675-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/c5d0c03a83f8/nihms-1768675-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/820956710a77/nihms-1768675-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/2853f9d88017/nihms-1768675-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/497cbf5c3e76/nihms-1768675-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/5a4ecaee9f3b/nihms-1768675-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/ffccaef3a2d5/nihms-1768675-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/b188584d3609/nihms-1768675-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/1be7603ec2d6/nihms-1768675-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/c5d0c03a83f8/nihms-1768675-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/820956710a77/nihms-1768675-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/2853f9d88017/nihms-1768675-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/497cbf5c3e76/nihms-1768675-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d5/8791450/5a4ecaee9f3b/nihms-1768675-f0008.jpg

相似文献

1
A Long Residence Time Enoyl-Reductase Inhibitor Explores an Extended Binding Region with Isoenzyme-Dependent Tautomer Adaptation and Differential Substrate-Binding Loop Closure.一种长停留时间烯酰还原酶抑制剂通过同工酶依赖性互变异构适应和不同的底物结合环闭合来探索扩展结合区域。
ACS Infect Dis. 2021 Apr 9;7(4):746-758. doi: 10.1021/acsinfecdis.0c00437. Epub 2021 Mar 12.
2
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis.一种缓慢、紧密结合的 InhA 抑制剂,来自结核分枝杆菌的烯酰基辅酶 A 还原酶。
J Biol Chem. 2010 May 7;285(19):14330-7. doi: 10.1074/jbc.M109.090373. Epub 2010 Mar 3.
3
A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA.结核分枝杆菌烯酰-ACP还原酶InhA慢发性抑制的结构与能量模型
ACS Chem Biol. 2014 Apr 18;9(4):986-93. doi: 10.1021/cb400896g. Epub 2014 Mar 10.
4
Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.芳基酰胺对结核分枝杆菌烯酰基酰基载体蛋白还原酶InhA的抑制作用。
Bioorg Med Chem. 2007 Nov 1;15(21):6649-58. doi: 10.1016/j.bmc.2007.08.013. Epub 2007 Aug 15.
5
Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus.金黄色葡萄球菌烯酰还原酶saFabI的作用机制与抑制作用
Biochemistry. 2008 Apr 8;47(14):4228-36. doi: 10.1021/bi800023a. Epub 2008 Mar 13.
6
Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.异烟肼-NAD加合物互变异构体与结核分枝杆菌烯酰-ACP还原酶(InhA)活性位点的结合:一种理论方法。
J Mol Graph Model. 2008 Nov;27(4):536-45. doi: 10.1016/j.jmgm.2008.09.006. Epub 2008 Sep 17.
7
Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.基于吡啶酮和二苯醚的抑制剂对鼠疫耶尔森菌FabV烯酰-ACP还原酶的选择性
Biochemistry. 2016 May 31;55(21):2992-3006. doi: 10.1021/acs.biochem.5b01301. Epub 2016 May 17.
8
Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.合理优化药物-靶标停留时间:抑制剂与金黄色葡萄球菌 FabI 酶-产物复合物结合的启示。
Biochemistry. 2013 Jun 18;52(24):4217-28. doi: 10.1021/bi400413c. Epub 2013 Jun 6.
9
Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data.通过抑制烯酰还原酶靶向结核病和疟疾:化合物活性与结构数据
J Biol Chem. 2003 Jun 6;278(23):20851-9. doi: 10.1074/jbc.M211968200. Epub 2003 Feb 26.
10
Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.设计、3-(9H-芴-9-基)吡咯烷-2,5-二酮衍生物的化学合成及对烯酰基辅酶 A 还原酶(InhA)和结核分枝杆菌的生物活性。
Eur J Med Chem. 2013;70:37-48. doi: 10.1016/j.ejmech.2013.09.041. Epub 2013 Oct 2.

引用本文的文献

1
Residence time in drug discovery: current insights and future perspectives.药物研发中的驻留时间:当前见解与未来展望。
Pharmacol Rep. 2025 Jun 9. doi: 10.1007/s43440-025-00748-z.
2
Is Mycobacterial InhA a Suitable Target for Rational Drug Design?分枝杆菌InhA是合理药物设计的合适靶点吗?
ChemMedChem. 2025 Jul 1;20(13):e202500079. doi: 10.1002/cmdc.202500079. Epub 2025 Apr 29.
3
Evaluating the Impact of the Tyr158 p on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from .评估 Tyr158p 对 InhA(烯酰基辅酶 A 还原酶)的机制和抑制的影响,InhA 来自 。

本文引用的文献

1
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.合理化对嗜麦芽窄食单胞菌FabI1烯酰-ACP还原酶抑制作用的结合动力学
Biochemistry. 2017 Apr 4;56(13):1865-1878. doi: 10.1021/acs.biochem.6b01048. Epub 2017 Mar 21.
2
Getting the chemistry right: protonation, tautomers and the importance of H atoms in biological chemistry.把握化学本质:质子化、互变异构体和 H 原子在生物化学中的重要性。
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):131-140. doi: 10.1107/S2059798316020283.
3
Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors.
Biochemistry. 2023 Jun 20;62(12):1943-1952. doi: 10.1021/acs.biochem.2c00606. Epub 2023 Jun 4.
评估过渡态去稳定化对唑类 InhA 抑制剂停留时间变化的贡献。
J Am Chem Soc. 2017 Mar 8;139(9):3417-3429. doi: 10.1021/jacs.6b11148. Epub 2017 Feb 22.
4
Correlating Drug-Target Kinetics and Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.关联药物-靶点动力学与药效学:FabI烯酰-ACP还原酶的长驻留时间抑制剂
Chem Sci. 2016 Sep 1;7(9):5945-5954. doi: 10.1039/C6SC01000H. Epub 2016 May 25.
5
Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities.首款针对葡萄球菌的抗菌药物AFN-1252治疗急性细菌性皮肤和皮肤结构感染(包括伴有严重合并症患者的感染)的疗效和安全性。
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1695-701. doi: 10.1128/AAC.01741-15.
6
Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.结核分枝杆菌耐药机制:2015年更新
Int J Tuberc Lung Dis. 2015 Nov;19(11):1276-89. doi: 10.5588/ijtld.15.0389.
7
Rational Modulation of the Induced-Fit Conformational Change for Slow-Onset Inhibition in Mycobacterium tuberculosis InhA.结核分枝杆菌InhA中慢发性抑制的诱导契合构象变化的合理调控
Biochemistry. 2015 Aug 4;54(30):4683-91. doi: 10.1021/acs.biochem.5b00284. Epub 2015 Jul 24.
8
Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.结核分枝杆菌InhA的慢发性抑制:通过分子动力学模拟揭示停留时间的分子决定因素
PLoS One. 2015 May 21;10(5):e0127009. doi: 10.1371/journal.pone.0127009. eCollection 2015.
9
Design strategies to address kinetics of drug binding and residence time.设计应对药物结合动力学和驻留时间的策略。
Bioorg Med Chem Lett. 2015;25(10):2019-27. doi: 10.1016/j.bmcl.2015.02.027. Epub 2015 Mar 5.
10
Molecular mechanisms of antibiotic resistance.抗生素耐药性的分子机制。
Nat Rev Microbiol. 2015 Jan;13(1):42-51. doi: 10.1038/nrmicro3380. Epub 2014 Dec 1.